This hypothesis will imply that a minimal albumin loss, without any clinical symptoms of hypoalbuminaemia, might be beneficial, allowing a decrease in PBTU levels that have been difficult to eliminate with extracorporeal strategies until now. This evidence concerns the gene ALB and Hypoalbuminemia.